Bioaffinity Technologiew-27BIAFWPreferred / convertible
13F holders, Q3 2025 (September 30)3holders −1
0new positions
1sold out
1famous investor
$0.35avg. 13F price*
At the end of Q3 2025, 3 institutions reported holding Bioaffinity Technologiew-27 (BIAFW) in their 13F filings, down 1 from Q2 2025. 0 opened new positions and 1 sold out. The largest holders were Clear Street Group Inc. ($18K), UBS Group AG ($16K) and Citadel Advisors ($13K). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Bioaffinity Technologiew-27
- CUSIP
- 09076W117
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $27K |
All 13F filers, Q2 2025 → Q3 2025: 206,756 shares sold, net −206,756 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Clear Street Group Inc. | — | — | 55,320 | $18K |
| UBS Group AG | — | Reduce -1.9% | 47,669 | $16K |
| Citadel Advisors | — | Reduce -5.5% | 30,584 | $13K |
"% of holder's portfolio" is BIAFW's weight in each manager's 13F, not the share of Bioaffinity Technologiew-27 the manager owns.